March 2021

BC-CfE researches understudied gbMSM subgroup’s cardiovascular health

A BC-CfE-led team of interdisciplinary researchers recently published their work in the Canadian Journal of Human Sexuality examining the cardiovascular health of an understudied subgroup among gay, bisexual and other men who have sex with men (gbMSM)-“Assessing Bear/Cub/Otter identity and history of cardiovascular disease among gay, bisexual, and other men who have sex with men in Metro Vancouver

BC-CfE researches understudied gbMSM subgroup’s cardiovascular health Read More »

BC-CfE research provides real-world data on efficacy of generic cART

First introduced in the mid-1990s through the pioneering work of BC-CfE Executive Director and Physician-in-Chief Dr. Julio Montaner, combination antiretroviral therapy (cART) is a pillar of the Treatment as Prevention¨ strategy that has enabled people living with HIV to live longer and healthier lives and has dramatically reduced the risk of HIV transmission.

BC-CfE research provides real-world data on efficacy of generic cART Read More »

BC-CfE research on coronavirus evolution helps in vaccine design and deepens understanding of viral mutations

The BC-CfE continues to lead the way in COVID-19 research, with the latest published research on the topic coming from the Centre’s Molecular Epidemiology and Evolutionary Genetics Group.

The paper, which features contributions from almost all members of the group, focuses on evolutionary patterns among coronaviruses that have jumped from animal hosts into humans and is titled “Variable routes to genomic and host adaptation among coronaviruses“.

BC-CfE research on coronavirus evolution helps in vaccine design and deepens understanding of viral mutations Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below